23/08/2025
Update regarding the availablility of Pegasys in Australia: The Department of Health has advised that PBS reimbursement of Irish Pegasys® will commence from September 1st, 2025.
The supply of Irish labelled Pegasys® will predominantly be 180 mcg strength, as previously communicated, which will impact patients routinely prescribed the 135 mcg strength. Graduation marks exist at the 90 mcg, 135 mcg and 180 mcg doses, which is the same as the Australian labelled Pegasys®.
Patients who require a new script for 180 mcg should contact their treating haematologist as soon as possible.
All Australian patients on Pegasys® will continue to receive their supply via JustMeds until Australian supplies of Pegasys® return to normal (late 2025).
Pegylated interferon alfa-2a Home Delivery Program How to access Pegylated interferon alfa-2a 4th August 2025 - New update from ECHO TherapeuticsRE: Update on Pegasys® shortage and supply of S19A Irish labelled Pegasys®Echo Therapeutics, the supplier of PEGASYS® peginterferon alfa-2a 135 mcg...
